Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hoffman

Showing results (911-920 of 1,048) with videos related to

Pageof 105
Sort By:
The Journal of Cell Biology|October 15, 2014
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophySherry Dadgar, Zuyi Wang, Helen Johnston, et al.
Human Molecular Genetics|May 23, 1998
Caveolin-3 in muscular dystrophyE M McNally, E de Sá Moreira, D J Duggan, et al.
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.
Journal of Strength and Conditioning Research|February 4, 2015
Examination of Lifestyle Behaviors and Cardiometabolic Risk Factors in University Students Enrolled in Kinesiology Degree ProgramsGina M Many, Andrea Lutsch, Kimberly E Connors, et al.
Physiological Genomics|April 24, 2003
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophyThomas P Cappola, Leslie Cope, Amy Cernetich, et al.
Steroids|September 16, 2025
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trialsAna de Vera, Paula R Clemens, Utkarsh J Dang, et al.
Journal of Neurology|March 3, 2026
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophyHanns Lochmüller, Hernan Gonorazky, Elisa Nigro, et al.
The American Journal of Pathology|June 27, 2007
SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathwayVanessa M Freitas, Vanessa F Vilas-Boas, Daniel C Pimenta, et al.
Muscle & Nerve|March 5, 2009
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measuresChristopher F Spurney, Heather Gordish-Dressman, Alfredo D Guerron, et al.
Experimental Physiology|July 26, 2016
OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophagesGina M Many, Yasuyuki Yokosaki, Kitipong Uaesoontrachoon, et al.
Pageof 105

Showing results (911-920 of 1,048) with videos related to

Sort By:
Pageof 105
The Journal of Cell Biology|October 15, 2014
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophySherry Dadgar, Zuyi Wang, Helen Johnston, et al.
Human Molecular Genetics|May 23, 1998
Caveolin-3 in muscular dystrophyE M McNally, E de Sá Moreira, D J Duggan, et al.
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.
Journal of Strength and Conditioning Research|February 4, 2015
Examination of Lifestyle Behaviors and Cardiometabolic Risk Factors in University Students Enrolled in Kinesiology Degree ProgramsGina M Many, Andrea Lutsch, Kimberly E Connors, et al.
Physiological Genomics|April 24, 2003
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophyThomas P Cappola, Leslie Cope, Amy Cernetich, et al.
Steroids|September 16, 2025
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trialsAna de Vera, Paula R Clemens, Utkarsh J Dang, et al.
Journal of Neurology|March 3, 2026
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophyHanns Lochmüller, Hernan Gonorazky, Elisa Nigro, et al.
The American Journal of Pathology|June 27, 2007
SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathwayVanessa M Freitas, Vanessa F Vilas-Boas, Daniel C Pimenta, et al.
Muscle & Nerve|March 5, 2009
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measuresChristopher F Spurney, Heather Gordish-Dressman, Alfredo D Guerron, et al.
Experimental Physiology|July 26, 2016
OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophagesGina M Many, Yasuyuki Yokosaki, Kitipong Uaesoontrachoon, et al.
Pageof 105